Article
Patent Term Extensions And Exclusivity Amid Blockbuster Drug Patent Expirations
When AbbVie and Amgen agreed a settlement over Humira back in 2017, the prospect of AbbVie's blockbuster drug being impacted by biosimilar competition seemed a long way in the future.

Potter Clarkson LLP



